Back to Search
Start Over
Results of a phase 2 trial of selinexor, an oral selective inhibitor of nuclear export (SINE) in 114 patients with gynaecological cancers
- Source :
- Vergote, I, Lund, B, Havsteen, H, Ujmajuridze, Z, Van Nieuwenhuysen, E, Haslund, C, Juhler-Nottrup, T, Neven, P, Mau-Sorensen, M, Berteloot, P, Kranich, A L, Rashal, T, Meade, J, Landesman, Y, Saint-Martin, J-R, Wright, G, Crochiere, M, Shacham, S, Kauffman, M & Mirza, M R 2016, ' Results of a phase 2 trial of selinexor, an oral selective inhibitor of nuclear export (SINE) in 114 patients with gynaecological cancers ', Annals of Oncology, vol. 27, no. Suppl. 6, 8540O . https://doi.org/10.1093/annonc/mdw374.01
- Publication Year :
- 2016
Details
- Language :
- English
- Database :
- OpenAIRE
- Journal :
- Vergote, I, Lund, B, Havsteen, H, Ujmajuridze, Z, Van Nieuwenhuysen, E, Haslund, C, Juhler-Nottrup, T, Neven, P, Mau-Sorensen, M, Berteloot, P, Kranich, A L, Rashal, T, Meade, J, Landesman, Y, Saint-Martin, J-R, Wright, G, Crochiere, M, Shacham, S, Kauffman, M & Mirza, M R 2016, ' Results of a phase 2 trial of selinexor, an oral selective inhibitor of nuclear export (SINE) in 114 patients with gynaecological cancers ', Annals of Oncology, vol. 27, no. Suppl. 6, 8540O . https://doi.org/10.1093/annonc/mdw374.01
- Accession number :
- edsair.doi.dedup.....a3917411dfd02bc2ba457ac9a2abf987